Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Revenue (2020 - 2025)

Journey Medical (DERM) has disclosed Revenue for 6 consecutive years, with $17.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue rose 16.38% year-over-year to $17.0 million, compared with a TTM value of $58.8 million through Sep 2025, up 53.7%, and an annual FY2024 reading of $56.1 million, down 5.91% over the prior year.
  • Revenue was $17.0 million for Q3 2025 at Journey Medical, up from $15.0 million in the prior quarter.
  • Across five years, Revenue topped out at $34.5 million in Q3 2023 and bottomed at -$4.3 million in Q4 2023.
  • Average Revenue over 5 years is $15.7 million, with a median of $15.3 million recorded in 2021.
  • The sharpest move saw Revenue tumbled 126.77% in 2023, then skyrocketed 419.57% in 2024.
  • Year by year, Revenue stood at $17.5 million in 2021, then decreased by 9.11% to $15.9 million in 2022, then crashed by 126.77% to -$4.3 million in 2023, then surged by 419.57% to $13.6 million in 2024, then increased by 25.0% to $17.0 million in 2025.
  • Business Quant data shows Revenue for DERM at $17.0 million in Q3 2025, $15.0 million in Q2 2025, and $13.1 million in Q1 2025.